Brazil: medtechs face supply continuity rules
This article was originally published in Clinica
Executive Summary
In an unprecedented move, Brazil is to draw up legislation obliging medtech and pharma suppliers to actively help avert any disruption to the market when planning to suspend production of or withdraw a product.